PHARMACY

Dr. Reddy’s launches generic Tobi

BY Sandra Levy

Dr. Reddy’s is introducing tobramycin inhalation solution. The product is the generic of Mylans‘s Tobi (tobramycin) inhalation solution

The Tobi (tobramycin) inhalation solution brand and generic had a market value of approximately $97 million, for the most recent 12 months ended April 2019, according to IQVIA.

Dr. Reddy’s product is available in a 300 mg/5 mL single-dose ampule.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer